Pharming Receives Over 800,000 Shares from Trust Foundation
29 avr. 2005 12h17 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, April 29, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHAR.AS) announced today that the Company is the beneficiary of over 800,000...
Pharming Announces Annual Shareholders Meeting
22 avr. 2005 02h06 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, April 22, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHAR.AS) announced that the Company's annual shareholders meeting (AGM) will be...
Pharming to Present at UBS Northern Europe Conference
11 avr. 2005 05h34 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, April 11, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHAR.AS) announced today that the Company will present at the UBS Northern...
Pharming Included in Next 150 Index on Euronext
24 mars 2005 07h08 HE
|
Pharming Group N.V.
LEIDEN, The Netherlands, March 24, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHAR.AS) (Other OTC:PHGUF) announced today that the Company has been...
Pharming Initates Phase III Clinical Trial for C1 Inhibitor in Europe
28 avr. 2004 12h09 HE
|
Pharming Group N.V.
LEIDEN, The Netherlands, April 28, 2004 (PRIMEZONE) -- Pharming Group N.V. (Euronext: PHARM; "Pharming" or "the Company") announced today that it has initiated the pivotal Phase III clinical trial...